James Thomson is the best known stem-cell scientist at UW-Madison — probably in the country, and perhaps in the world.
But dozens of other campus researchers are exploring the cells' potential for disease treatments, drug screening and lessons about human biology. Some of their work involves induced pluripotent cells, reprogrammed skin cells announced by Thomson in November. Known as iPS cells, they are similar to embryonic stem cells. Here's a look at five other stars.